This is a preview of subscription content, log in via an institution to check access.
References
Tham E, Grandell U, Lindgren E, Toss G, Skogseid B, Nordenskjöld M. Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. J Clin Endocrinol Metab 2007, 92: 3389–95.
Kouvaraki MA, Lee JE, Shapiro SE, et al. Genotype-Phenotype Analysis in Multiple Endocrine Neoplasia Type 1. Arch Surg 2002, 137: 641–7.
Marini F, Falchetti A, Del Monte F, et al. Multiple endocrine neoplasia type 1. Orphanet J Rare Dis 2006, 1: 38.
Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001, 86: 5658–71.
Doherty GM. Multiple endocrine neoplasia type 1. J Surg Oncol 2005, 89: 143–50.
Tsukada T, Nagamura Y, Ohkura N. MEN1 gene and its mutations: Basic and clinical implications. Cancer Sci 2008, 100: 209–15.
Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 2008, 29: 22–32.
Asgharian B, Chen YJ, Patronas NJ, et al. Meningiomas may be a component tumor of multiple endocrine neoplasia type 1. Clin Cancer Res 2004, 10: 869–80.
Gardner DG. Multiple Endocrine Neoplasia. In: Gardner DG, Shoback D, eds. Greenspan’s Basic and Clinical Endocrinology. 8th ed. New York: McGraw-Hill. 2007, 831–43.
Piecha G, Chudek J, Wiecek A. Multiple endocrine neoplasia type 1. Eur J Intern Med 2008, 19: 99–103.
Alexakis N, Neoptolemos JP. Pancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol 2008, 22: 183–205.
Feliciano DV. Parathyroid pathology in an intrathyroidal position. Am J Surg 1992, 164: 496–500.
Hellman P, Skogseid B, Oberg K, Juhlin C, Akerström G, Rastad J. Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery 1998, 124: 993–9.
Falchetti A, Marini F, Luzi E, Tonelli F, Brandi ML. Multiple endocrine neoplasms. Best Pract Res Clin Rheumatol 2008, 22: 149–63.
Shepherd JJ. The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized? Arch Surg 1991, 126: 935–52.
Kato H, Uchimura I, Morohoshi M, et al. Multiple endocrine neoplasia type 1 associated with spinal ependymoma. Intern Med 1996, 354: 285–9.
Giraud S, Choplin H, Teh BT, et al. A large multiple endocrine neoplasia type 1 family with clinical expression suggestive of anticipation. J Clin Endocrinol Metab 1997, 82: 3487–92.
Dimopoulos VG, Fountas KN, Robinson JS. Familial intracranial ependymomas. Report of three cases in a family and review of the literature. Neurosurg Focus 2006, 20: E8.
Dal Cin P, Sandberg AA. Cytogenetic findings in a supratentorial ependymoma. Cancer Genet Cytogenet 1988, 30: 289–93.
Sainati L, Montaldi A, Putti MC, et al. Cytogenetic t(11;17)(q13;q21) in a pediatric ependymoma. Is 11q13 a recurring breakpoint in ependymomas? Cancer Genet Cytogenet 1992, 59: 213–6.
Ransom DT, Ritland SR, Kimmel DW, et al. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genes Chromosomes Cancer 1992, 5: 348–56.
Rousseau E, Palm T, Scaravilli F, et al. Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma. Mol Cancer 2007, 6: 47.
Lamszus K, Lachenmayer L, Heinemann U, et al. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas. Int J Cancer 2001, 91: 803–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Al-Salameh, A., François, P., Giraud, S. et al. Intracranial ependymoma associated with multiple endocrine neoplasia type 1. J Endocrinol Invest 33, 353–356 (2010). https://doi.org/10.1007/BF03346599
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346599